![](/img/cover-not-exists.png)
O001 Randomized, double-blind, placebo-controlled trial of recombinant human C1 inhibitor for prophylaxis of hereditary angioedema attacks
Cicardi, M., Riedl, M., Grivcheva Panovska, V., Moldovan, D., Baker, J., Yang, W., Reshef, A., Andrejevic, S., Lockey, R., Hakl, R., Kivity, S., Bellizzi, L., Harper, J., Relan, A.Volume:
117
Language:
english
Journal:
Annals of Allergy, Asthma & Immunology
DOI:
10.1016/j.anai.2016.09.361
Date:
November, 2016
File:
PDF, 264 KB
english, 2016